May 05, 2025 07:25 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pahalgam fallout: India suspends Pakistan I&B minister Ataullah Tarar's X account | India bans all imports from Pakistan in Pahalgam terror attack fallout | Yunus aide threatens Bangladesh would occupy North East states if India attacks Pakistan | Pahalgam aftermath: Pakistan test-fires ballistic missile with 450-km range amid escalation in tension with India | 'Your govt stands at a historic crossroads': Tejashwi Yadav to PM Modi on caste census move | Pahalgam attack: Supreme Court stays deportation of PoK-born man, his family with Indian passports | Cops charge OTT show's host Ajaz Khan, producer Rajkymar Pandey over 'sex positions' viral clip | 7.4 magnitude earthquake strikes off coast of Chile and Argentina, tsunami warning issued | PM Modi inaugurates Vizhinjam International Seaport in Kerala worth Rs. 8,800 crore | 'Many will get their sleep disturbed': Modi's veiled jibe at Congress over Shashi Tharoor, Pinarayi Vijayan's presence at Kerala event
Sputnik V

One dose of Russia's Sputnik V vaccine to cost less than $10 for int'l markets - RDIF

| @indiablooms | Nov 24, 2020, at 10:11 pm

Moscow/Sputnik: One dose of Russia's Sputnik V vaccine against COVID-19 will cost less than $10 for the international markets, which is two or more times cheaper than alternatives by Pfizer and Moderna, the Russian Direct Investment Fund (RDIF) announced on Tuesday.

While vaccines by US biotechnology company Moderna and the Pfizer pharmaceutical corporation are mRNA-based, like many other vaccine candidates, Russia's Sputnik V is based on the well-research method of human adenoviral vectors.

"The cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person. Thus, Sputnik V will be two or more times cheaper than foreign vaccines based on mRNA technology with similar efficacy rates," RDIF said in a press release. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu